45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
11,575
Insurances with rates
4
CPT / HCPCS codes
4,990
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J1411 | etranacogene dezaparvovec-drlb 1x10exp13 gc/mL Susp 1 Each KIT | $8,400,005 | $3,276,002 | — | — | 0 |
| Q2054 | lisocabtagene maraleuceL 1.5 x to 70 x 10exp6 cell/mL Susp 1 Each VIAL | $1,472,908 | $574,434 | — | — | 0 |
| J2326 | nusinersen (PF) 12 mg/5 mL Soln 5 mL VIAL | $386,234 | $150,631 | — | — | 0 |
| J0225 | vutrisiran 25 mg/0.5 mL Syringe 0.5 mL SYRINGE | $315,092 | $122,886 | — | — | 0 |
| J1412 | valoctocogene roxaparvovc-rvox 2 x 10exp13 vg/mL Susp 1 Each VIAL | $250,132 | $97,551 | — | — | 0 |
| A9543 | yttrium-90-ibritumomab 3.2 mg/2 mL Kit 1 Each VIAL | $195,328 | $76,178 | — | — | 1 |
| A9513 | lutetium Lu 177 dotatate 10 mCi/mL (370 MBq/mL) Soln 1 Each VIAL | $193,133 | $75,322 | — | — | 0 |
| J7174 | fitusiran 20 mg/0.2 mL Soln 0.2 mL VIAL | $185,938 | $72,516 | — | — | 0 |
| Q2043 | sipuleuceL-T in LR 50 million cell/250 mL Susp 250 mL BAG | $180,340 | $70,333 | — | — | 1 |
| J0224 | lumasiran 94.5 mg/0.5 mL Soln 0.5 mL VIAL | $173,090 | $67,505 | — | — | 0 |
| J1747 | Spesolimab-sbzo 60 mg/mL Soln 7.5 mL VIAL | $160,728 | $62,684 | — | — | 0 |
| A9607 | "lutetium Lu-177 vipivotide tetraxetan 27 mCi/mL (1,000 MBq/mL) Soln 1 Each VIAL" | $147,409 | $57,490 | — | — | 0 |
| J7352 | afamelanotide 16 mg Implant 1 Each VIAL | $145,183 | $56,622 | — | — | 0 |
| J9226 | histrelin 50 mg (65 mcg/day) Kit 1 Each KIT | $144,528 | $56,366 | — | — | 1 |
| 90288 | botulism immune globulin (human) 100 mg Recon soln 1 Each VIAL | $137,525 | $53,635 | — | — | 0 |
| teduglutide 5 mg Kit 1 Each KIT | teduglutide 5 mg Kit 1 Each KIT | $135,056 | $52,672 | — | — | 0 |
| J1823 | inebilizumab-cdon 10 mg/mL Soln 10 mL VIAL | $134,644 | $52,511 | — | — | 0 |
| sodium benzoate-sod phenylacet 10-10 % Soln 50 m | sodium benzoate-sod phenylacet 10-10 % Soln 50 mL VIAL | $131,508 | $51,288 | — | — | 0 |
| J0223 | givosiran 189 mg/mL Soln 1 mL VIAL | $126,420 | $49,304 | — | — | 0 |
| C9293 | "glucarpidase 1,000 unit Recon soln 1 Each VIAL" | $124,516 | $48,561 | — | — | 1 |
| J9347 | tremelimumab-actl 20 mg/mL Soln 15 mL VIAL | $119,240 | $46,504 | — | — | 0 |
| J2351 | "ocrelizumab-hyaluronidase-ocsq 920 mg-23,000 unit/23 mL Soln 23 mL VIAL" | $118,897 | $46,370 | — | — | 0 |
| 69930 | COCHLEAR DEVICE IMPLANTATION W/WO MASTOIDECTOMY | $104,714 | $40,838 | — | — | 3 |
| J9269 | "tagraxofusp-erzs 1,000 mcg/mL Soln 1 mL VIAL" | $97,264 | $37,933 | — | — | 0 |
| C9767 | REV EVAR ANY VES;IV LITHO&TL STNT PLCMT&ATHERECT | $95,941 | $37,417 | — | — | 1 |
| J2507 | pegloticase 8 mg/mL Soln 1 mL VIAL | $88,545 | $34,532 | — | — | 1 |
| A9606 | "radium Ra 223 dichloride 1,100 kBq/mL(30 microcurie/mL) Soln 1 Each VIAL" | $86,651 | $33,794 | — | — | 1 |
| J9118 | calaspargase pegol-mknl 750 unit/mL Soln 5 mL VIAL | $85,760 | $33,446 | — | — | 0 |
| J0202 | alemtuzumab 12 mg/1.2 mL Soln 1.2 mL VIAL | $85,668 | $33,411 | — | — | 1 |
| Bexarotene 1 % Gel 60 g TUBE | Bexarotene 1 % Gel 60 g TUBE | $83,983 | $32,753 | — | — | 0 |
| J9359 | loncastuximab tesirine-lpyL 10 mg Recon soln 1 Each VIAL | $81,612 | $31,829 | — | — | 0 |
| J9266 | pegaspargase in sterile diluent 750 UNIT/ML Inj 5 mL VIAL | $79,203 | $30,889 | — | — | 1 |
| J1951 | leuprolide (pediatric 6 month) 45 mg Syringe 1 Each SYRINGE | $79,041 | $30,826 | — | — | 0 |
| 33264 | RMVL IMPLTBL DFB PLS GEN W/RPLCMT PLS GEN MLT LD | $78,245 | $30,516 | — | — | 2 |
| 33270 | INS/RPLCMNT PERM SUBQ IMPLTBL DFB W/SUBQ ELTRD | $78,245 | $30,516 | — | — | 2 |
| J0593 | lanadelumab-flyo 300 mg/2 mL (150 mg/mL) Soln 2 mL VIAL | $75,901 | $29,601 | — | — | 0 |
| J9348 | naxitamab-gqgk 4 mg/mL Soln 10 mL VIAL | $75,115 | $29,295 | — | — | 0 |
| J9281 | mitoMYcin 40 mg x 2 Kit 1 Each VIAL | $73,287 | $28,582 | — | — | 0 |
| J3401 | Beremagene geperpavec-svdt 5 x 10exp9 PFU/2.5 mL Gel 2.5 mL VIAL | $72,667 | $28,340 | — | — | 0 |
| ribavirin 6 gram Recon soln 4 Each VIAL | ribavirin 6 gram Recon soln 4 Each VIAL | $71,893 | $28,038 | — | — | 0 |
| Uridine Triacetate 2 gram Granules pkt 30 Each P | Uridine Triacetate 2 gram Granules pkt 30 Each PACKET | $71,446 | $27,864 | — | — | 0 |
| 0505T | EV FEMPOP ARTL REVSC TCAT PLMT IV ST GRF & CLSR | $70,551 | $27,515 | — | — | 1 |
| belantamab mafodotin-blmf 70 mg Recon soln 1 Eac | belantamab mafodotin-blmf 70 mg Recon soln 1 Each VIAL | $69,165 | $26,974 | — | — | 0 |
| J1303 | ravulizumab-cwvz 100 mg/mL Soln 11 mL VIAL | $68,984 | $26,904 | — | — | 0 |
| J9229 | inotuzumab ozogamicin 0.9 mg (0.25 mg/mL initial) Recon soln 1 Each VIAL | $68,923 | $26,880 | — | — | 0 |
| 0620T | ENDOVASCULAR VENOUS ARTERIALIZATION TIBL/PRNL VN | $67,206 | $26,210 | — | — | 1 |
| C9773 | REVASC LITHOTR-STENT TIB/PER | $67,206 | $26,210 | — | — | 1 |
| C9774 | REVASC LITHOTR-ATHER TIB/PER | $67,206 | $26,210 | — | — | 1 |
| C9775 | REVASC LITH-STEN-ATH TIB/PER | $67,206 | $26,210 | — | — | 1 |
| J9600 | porfimer 75 mg Recon soln 1 Each VIAL | $67,175 | $26,198 | — | — | 1 |
Showing top 50 of 11,575 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.